Medifast, Inc. (MED)
NYSEConsumer DiscretionaryPersonal Products & ServicesSnapshot 2026-09-04
$12.63+0.72%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryPersonal Products & ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · MED
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 316.9 | 385.8 | 602.5 | 1,072.1 | 1,598.6 | 1,526.1 | 934.8 | 713.7 | 501.0 | 301.6 | 274.5 | 272.8 | 285.3 | 324.1 | 318.6 | 298.2 |
| Total Revenues | — | — | — | — | — | — | 934.8 | 713.7 | 501.0 | 301.6 | 274.5 | 272.8 | 285.3 | 324.1 | 318.6 | 298.2 |
| Cost of Revenues | 97.5 | 110.6 | 157.8 | 296.2 | 458.2 | 398.5 | 237.0 | 176.8 | 121.1 | 73.8 | 68.9 | 71.5 | 76.1 | 83.5 | 82.7 | 73.7 |
| Gross Profit | 219.5 | 275.2 | 444.6 | 775.9 | 1,140.4 | 1,127.6 | 697.8 | 536.9 | 379.9 | 227.8 | 205.7 | 201.3 | 209.2 | 240.6 | 235.9 | 224.5 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 239.0 | 289.4 | 441.7 | 649.4 | 955.6 | 911.4 | 563.7 | 445.8 | 310.8 | 188.2 | 178.8 | 172.6 | 179.0 | 202.2 | 208.8 | 197.1 |
| R&D Expenses | — | 4.3 | 4.6 | 4.6 | 4.5 | 4.4 | 2.8 | 2.7 | 2.2 | 1.5 | 2.0 | — | — | — | — | — |
| Operating Income | (19.5) | (14.2) | 2.9 | 126.4 | 184.8 | 216.2 | 134.2 | 91.0 | 69.1 | 39.6 | 26.9 | 28.7 | 30.2 | 38.4 | 27.1 | 27.4 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 |
| Other Non-Operating Income / Expenses | 5.5 | 8.6 | 0.9 | 2.4 | (0.7) | (0.1) | 0.1 | 1.3 | 1.5 | 0.7 | 0.3 | 1.0 | 1.4 | 0.6 | 1.2 | 0.3 |
| EBT, Incl. Unusual Items | (14.0) | (5.6) | 3.8 | 128.8 | 184.1 | 216.1 | 134.3 | 92.4 | 70.5 | 40.3 | 27.1 | 29.7 | 31.7 | 39.0 | 28.4 | 27.7 |
| Income Tax Expense | 11.6 | 13.0 | 1.7 | 29.4 | 40.5 | 52.1 | 31.4 | 14.4 | 14.8 | 12.6 | 9.3 | 10.1 | 10.7 | 11.9 | 9.9 | 9.1 |
| Net Income | ||||||||||||||||
| Net Income | (25.9) | (18.7) | 2.1 | 99.0 | 144.0 | 164.0 | 102.9 | 77.9 | 55.8 | 27.7 | 17.8 | 20.1 | 13.2 | 24.0 | 15.9 | 18.5 |
| Per Share | ||||||||||||||||
| Basic EPS | (2.33) | (1.70) | 0.19 | 9.13 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 | 2.32 | 1.51 | 1.68 | 1.04 | 1.74 | 1.16 | 1.33 |
| Diluted EPS | (2.33) | (1.70) | 0.19 | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 | 4.62 | 2.29 | 1.49 | 1.66 | 1.03 | 1.73 | 1.16 | 1.31 |
| Revenue per Share | 28.46 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 4.95 | 6.56 | 5.68 | 4.52 | 3.38 | 2.19 | 1.44 | 1.07 | 0.25 | — | — | — | — |
| Basic Weighted Avg Shares | 11.1 | 11.0 | 10.9 | 10.9 | 11.2 | 11.7 | 11.8 | 11.8 | 11.9 | 11.9 | 11.8 | 12.0 | 12.7 | 13.8 | 13.7 | 14.0 |
| Diluted Weighted Avg Shares | 11.1 | 11.0 | 11.0 | 10.9 | 11.3 | 11.8 | 11.9 | 12.1 | 12.1 | 12.1 | 11.9 | 12.1 | 12.8 | 13.8 | 13.7 | 14.2 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 0.0 | 15.6 | 139.5 | 195.8 | 223.1 | 138.5 | 95.7 | 73.5 | 43.8 | 32.3 | 35.8 | 38.3 | 46.3 | 37.3 | 34.4 |
| EBIT | (19.5) | (14.2) | 2.9 | 126.4 | 184.8 | 216.2 | 134.2 | 91.0 | 69.1 | 39.6 | 26.9 | 28.7 | 30.2 | 38.4 | 27.1 | 27.4 |
| Effective Tax Rate | -83.2% | — | — | 22.8% | 22.0% | 24.1% | 23.4% | 15.6% | 20.9% | 31.3% | 34.2% | 34.1% | 33.6% | 30.5% | 35.0% | 33.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.